| Value | ₹650.0 Cr |
|---|
NSE filing, NSE: AEQUS. Summary written from the filing by ALFA Finder's alert engine.
Aequs Ltd: key numbers
- Share price
- ₹222.64
- Market cap
- ₹14,932 Cr
- Revenue (annual)
- ₹1,230 Cr
- Net profit (annual)
- ₹-113.2 Cr
- P/E (TTM)
- -73.9×Sector 52.6×
- Promoter holding
- 59.09%+0.00% QoQ
- FII holding
- 5.93%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Aequs Ltd
All →Aequs Preferential Issue
Aequs Limited allotted 28,071,690 warrants convertible into equity at Rs 231.55 each to a promoter trust. The allotment aggregates to about Rs 650 Crore under a preferential issue.
- Value
- ₹650.0 Cr
Aequs Other Announcement
Aequs filed CARE Ratings' quarterly monitoring report on its IPO proceeds for the quarter ended September 2026. The report found no deviation from the stated objects.
Aequs Earnings Call Transcript: Key Takeaways
Aerospace's strong 44% growth is being overshadowed by execution delays and inventory write-downs in the consumer business.
- Call
- Guides 400% growth
Aequs Employee Stock Options
Aequs Limited's NRC granted 2,00,000 employee stock options under its ESOP 2025 plan at an exercise price of ₹235.50. The grant is an employee incentive step, with no cash raised by the company.
- Execution
- Options vest over a minimum of 1 year and are exercisable within 3 years of vesting
Aequs Results Update
Aequs Q2 FY27 revenue rose 45% YoY, but EBITDA fell 45% and losses widened. Consumer ramp slowed, while ₹6,500 Mn promoter warrants fund expansion.
Aequs Investor Presentation: Key Takeaways
H1 FY27 revenue ₹8,046 Mn (+50% YoY); EBITDA ₹460 Mn (6% margin); PAT loss ₹(1,054) Mn as Consumer ramp costs hit.
Other convertible warrants announcements
All →Flywings Simulator Training Centre Convertible Warrants
Flywings seeks approval to issue up to 29.88 lakh warrants at Rs.245, aggregating Rs.73.20 Crore. Includes promoter Rupal Mandavia; EGM is on 27 November 2026.
- Value
- ₹73.20 Cr
- Execution
- Warrants exercisable within 18 months from the date of allotment
Godavari Drugs Convertible Warrants
Godavari Drugs allotted 7,86,690 equity shares to promoter-category allottees on conversion of warrants. The balance consideration of Rs 5.25 Crore was received at an issue price of Rs 89.
- Value
- ₹5.25 Cr
Sahana System Convertible Warrants
Sahana System has issued a corrigendum to its postal ballot notice on warrant issuance. Warrants total ₹125 Crore at ₹950 each to identified allottees.
- Value
- ₹125.0 Cr
- Execution
- Warrant conversion within eighteen (18) months
Dev Labtech Venture Convertible Warrants
Dev Labtech Venture approved issuance of up to 1.37 crore convertible warrants at Rs.13 each to promoters and non-promoters on preferential basis. The issue aggregates Rs.17.81 Crore for cash.
- Value
- ₹17.81 Cr
Bajaj Finance Convertible Warrants
Bajaj Finance's special committee meets on 10 November 2026 to approve the price for warrants issued to the promoter. This is a pricing step of a promoter warrant issue.
Dev Labtech Venture Convertible Warrants
Dev Labtech Venture's EGM passed an authorised capital increase and a convertible warrant issue, both with 100% votes in favour. Promoters did not vote on the warrants.